Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Mammalian MAP kinase signalling cascades

Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353

Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation

Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400

Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R. P., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,477

The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases

Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,423

A Human Homolog of Angiotensin-converting Enzyme

Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041

The Genome Sequence of the SARS-Associated Coronavirus

Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A. R., Butterfield, Y. S. N., Khattra, J. S., Asano, J. K., Barber, S., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,027

Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico CityPreprint

Cérbulo‐Vázquez, A., Zavala-Barrios, B., Briones‐Garduño, J. C., Guerrero‐Avendaño, G., Arriaga‐Pizano, L., Ferat-Osorio, E. A., Cabrera‐Rivera, G. L., Miranda‐Cruz, P. E., la Rosa, M. T. G.-D., Prieto‐Chávez, J. L., et al. (2020) · medRxiv · doi:10.1101/2020.07.14.20153585 · Cited by 3

Ciclesonide Use in COVID-19: Not All Steroids Are the Same

Tagliati, M., Leopoulou, M., LeQuang, J. A., Wollmuth, C. E., Pergolizzi, J. V., Mitchell, K., & Magnusson, P. (2021) · Pharmacology & Pharmacy · doi:10.4236/pp.2021.121002 · Cited by 2

Macropinocytosis and SARS-CoV-2 cell entry

Sun, X., Zheng, W., Hua, R., Liu, Y., Wang, L., Kim, Y., Liu, X., Mimuro, H., Shen, Z., Li, L., et al. (2021) · Blood and Genomics · doi:10.46701/bg.2021012021110 · Cited by 1

COVID-19 Diagnosis, Treatments and Prevention: A Review

Chatterjee, S., & Chatterjee, S. (2020) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2020/v32i1730637 · Cited by 2

Network Representation Learning-Based Drug Mechanism Discovery and Anti-Inflammatory Response Against COVID-19Preprint

Wang, X., Xin, B., Xu, Z., Kenli, L. I., Li, F., Wu, Z., Tan, W., & Peng, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12531314.v1 · Cited by 2

Evidence of a dysregulated Vitamin D pathway in SARS-CoV-2 infected patient’s lung cellsPreprint

George, B., Amjesh, R., Paul, A. M., Kumar, T. R. S., Pillai, M. R., & Kumar, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.21.423733 · Cited by 2

The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial

Karolak, I., Hrynkiewicz, R., Niedźwiedzka‐Rystwej, P., Lechowicz, K., Sieńko, J., Szylińska, A., Dąbrowski, W., & Kotfis, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814247 · Cited by 1

Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS‐CoV‐2 Infection With and Without Diabetes

Yuan, M., Wassef, A. M., Sargsyan, D., Nersisyan, V., Cabrera, J., Nahass, R., Hassan, W. A., Kong, A. T., & Brunetti, L. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70425 · Cited by 1

Preface

(1956) · Annual Review of Microbiology · doi:10.1146/annurev.mi.10.073106.100001 · Cited by 1

A Bioelectromagnetic Proposal Approaching the Complex Challenges of COVID-19

Szász, A. (2020) · Open Journal of Biophysics · doi:10.4236/ojbiphy.2021.111001 · Cited by 1

Viral Respiratory Coinfections Enhance the Spread of SARS-CoV-2

Hedayati, M. A. (2021) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001056 · Cited by 1

Starting signal: Aberrant kinase activation as a trigger for SARS-CoV-2 induced axonal damage

Richards, A. L., & Jaenisch, R. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.973997 · Cited by 1

The percentage of Monocytes CD39+ is higher in Pregnant COVID-19 than in Non-Pregnant COVID-19 patientsPreprint

Cérbulo‐Vázquez, A., García-Espinosa, M., Briones‐Garduño, J. C., Arriaga‐Pizano, L., Ferat-Osorio, E. A., Zavala-Barrios, B., Cabrera‐Rivera, G. L., Miranda‐Cruz, P. E., la Rosa, M. T. G.-D., Prieto‐Chávez, J. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.18.449054 · Cited by 1

Network Representation Learning-Based Drug Mechanism Discovery and Anti-Inflammatory Response Against COVID-19Preprint

Xiaoqi, W., Xin, B., Xu, Z., Kenli, L. I., Li, F., Zhong, W., Tan, W., & Peng, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12531314 · Cited by 1

Network Representation Learning-Based Drug Mechanism Discovery and Anti-Inflammatory Response Against COVID-19Preprint

Wang, X., Xin, B., Xu, Z., Kenli, L. I., Li, F., Zhong, W., Tan, W., & Peng, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12531314.v2 · Cited by 1

Host signaling and proteolytic pathways in the resolution or the exacerbation of coronavirus (CoV-2) infection in COVID-19 disease: what therapeutic targets?Preprint

Sallenave, J., & Guillot, L. (2020) · doi:10.31219/osf.io/rtfmx · Cited by 1

Targeting COVID-19 Based on PathogenesisPreprint

Chong, Z. Z., & Zhang, H. (2024) · doi:10.22541/au.170665667.71444709/v1

Renin-angiotensin System in the Pathogenesis of COVID-19 and Possible Drug Targets

Shankar, S. H., Vishwakarma, V., Kumar, A., Sharma, R., & Wig, N. (2021) · Journal of Primary Care Specialties · doi:10.4103/jopcs.jopcs_15_20

Lesion types, pathogenesis, pathological manifestations, and imaging findings of cardiovascular complications induced by coronavirus disease 2019

Yu, F., Zhou, Q., & Yu, D. (2021) · Radiology of Infectious Diseases · doi:10.4103/rid.rid_6_21

SARS Coronavirus

Lin, B., & Malanoski, A. P. (2014) · CRC Press eBooks · doi:10.1201/b16752-21

Virology of CoViD19

Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_2

Preface

(1972) · Annual Review of Microbiology · doi:10.1146/annurev.mi.26.080206.100001

Introduction

Gottesman, S. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-mi-68-082814-100001

Introduction

Gottesman, S. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-mi-67-082213-100001

Preface

(1971) · Annual Review of Microbiology · doi:10.1146/annurev.mi.25.080106.100001

Preface

Ornston, L. N. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.mi.51.080306.100001

Preface

Gottesman, S. (2010) · Annual Review of Microbiology · doi:10.1146/annurev-mi-64-090810-100001

Preface

(1961) · Annual Review of Microbiology · doi:10.1146/annurev.mi.15.080106.100001

Preface by Nick Ornston

Ornston, N. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.mi.60.082206.100001

Preface

(1962) · Annual Review of Microbiology · doi:10.1146/annurev.mi.16.080106.100001

Preface

Ornston, L. N. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.mi.50.080306.100001

Preface

Gottesman, S. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-mi-66-092012-100001

PRELIMINARY STUDY FOR COVID-19 DRUG DISCOVERY OF 30 PHYTOCHEMICAL COMPOUNDS FROM TETRAGONULA SP. PROPOLIS AS PAK1 INHIBITOR THROUGH MOLECULAR DOCKING

Asih, S. C., Sahlan, M., & NASIKIN, M. (2022) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2022.v14s3.25

Repurposing Anti-inflammatory Agents in the Potential Treatment of SARS-COV-2 Infection

Akhtar, A., Kaur, J., Chiu, M. N., & Sah, S. P. (2023) · Springer eBooks · doi:10.1007/978-981-19-5399-6_17

Effects of Chemokine Ligand 2 on Budding of Bovine Foamy Virus

Li, R., Wang, Z., Liu, C., Qiao, W., & Tan, J. (2023) · Viruses · doi:10.3390/v15091867

Cis regulatory elements: A novel communication route between the host cell and the SARS-CoV-2 genome

Mazumder, B., & Komar, A. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95646-8.00023-8

Protein kinase CK2α’ as a dual modulator of immune signaling and synaptic dysfunction in TauopathyPreprint

White, A., Gavrilyuk, P., Gu, P., Moya, R. F., Thurston, R., Fickak, A., Rozema, N. B., Keshavaram, P., Vermilyea, S., Schlichte, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.24.661391

Protein kinase CK2α′ as a dual modulator of neuroimmune signaling and synaptic dysfunction in tauopathy

White, A., Gavrilyuk, P., Gu, P., Moya, R. F., Thurston, R. H., Fickak, A., Rozema, N. B., Keshavaram, P., Vermilyea, S., Schlichte, R., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00563-3

Cytokine Storm, Inflammation and Immunity in COVID-19

Datta, C., & Bhattacharjee, A. (2025) · Medical virology · doi:10.1007/978-981-95-1426-7_9

Artepillin C as a Potential Anticancer Phytochemical: Chemistry, Bioavailability and Preclinical Insights

Nofal, W., Aloliqi, A. A., Mujtaba, M. A., Lakhanpal, S., Sharma, S., Verma, M., Pandey, P., & Khan, F. (2026) · Current Medicinal Chemistry · doi:10.2174/0109298673493386260711092835

Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1

Han, H., Luo, R., Long, X., Wang, Y., Zhu, Q., Tang, X., Zhu, R., Ma, Y., Zheng, Y., & Zou, C. (2024) · eLife · doi:10.7554/elife.85985 · Cited by 16

SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells

Patra, T., Meyer, K., Geerling, L., Isbell, T. S., Hoft, D. F., Brien, J. D., Pinto, A. K., Ray, R. B., & Ray, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009128 · Cited by 229

Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection

Zhuang, M., Cheng, Y., Zhang, J., Jiang, X., Wang, L., Deng, J., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26139 · Cited by 215

Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry

Haga, S., Yamamoto, N., Nakai-Murakami, C., Osawa, Y., Tokunaga, K., Sata, T., Yamamoto, N., Sasazuki, T., & Ishizaka, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711241105 · Cited by 521

Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS

He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 367